Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Palecomic
    Member
    • Aug 2010
    • 34

    PCR product normalization

    We're multiplexing quite variable PCR products from environmental samples in single runs on a 454 Junior. Increasing the multiplex level to the most cost effective (we've got lots of samples!) means making sure you get a similar number of reads for each sample. As it's a Junior and we get only 70,000 reads a run when we're cooking, at the higher numbers of samples it can mean getting no reads (after QC and removal of bad reads) for particular samples in the run.

    Initially I was carefully quantifying with PicoGreen and Invitrogen's Quant-it kits and diluting pools of products based on that. Typically amplicons range in abundance by 3 orders of magnitude, and (unintuitively) the low abundance amplicons tend to have many more reads. I wonder whether the kit is underestimating the amount of product (standard curves are linear with reproducibly good R^2 values)? The amplicons that are most abundant, and therefore diluted more are consistently the least represented in reads.

    My next approach has been to quantify all amplicons, dilute to a similar order of magnitude, re-quantify and dilute them all to the correct molecules/µl input. Which still shows significant variability and is mind-numbingly tedious (and therefore error-prone!).

    What other strategies do people use for normalization?

    Does anyone have experience of the SequalPrep plates from Invitrogen? Do they work as they say? I would expect them not to be good with low abundance products (for some samples I pool several PCR reactions in order to get sufficient product to sequence, but I could pre-concentrate with an Ampure Xp purification, prior to using the SequalPrep plate?).

    Thanks for your help

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Working...